Showing results (61-70 of 300) with videos related to
Sort By:
Pageof 30
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|June 28, 2007
[O-Twist Marker for marking breast cancer under neoadjuvant chemotherapy--first results]P Viehweg, K Fabel, A Petzold, et al.European Journal of Neurology|April 2, 2014
Neurofilament heavy chain as a marker of neuroaxonal pathology and prognosis in acute encephalitisJ Sellner, N W Davies, R S Howard, et al.Neuro-Degenerative Diseases|June 29, 2007
A systematic review and meta-analysis of CSF neurofilament protein levels as biomarkers in dementiaA Petzold, G Keir, J Warren, et al.European Journal of Neurology|September 10, 2017
Diagnostic accuracy of optical coherence tomography inter-eye percentage difference for optic neuritis in multiple sclerosisD Coric, L J Balk, B M J Uitdehaag, et al.Journal of Neurology|January 7, 2014
Retinal hyperaemia-related blood vessel artifacts are relevant to automated OCT layer segmentationL J Balk, M Mayer, B M J Uitdehaag, et al.Journal of Cell Science|April 1, 1994
Identification of MYO4, a second class V myosin gene in yeastB K Haarer, A Petzold, S H Lillie, et al.Brain Research Bulletin|August 12, 2003
Cerebrospinal fluid (CSF) and serum S100B: release and wash-out patternA Petzold, G Keir, D Lim, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 18, 2006
Axonal damage and outcome in subarachnoid haemorrhageA Petzold, G Keir, A Kay, et al.Neurocritical Care|July 9, 2009
The longitudinal profile of bilirubin and ferritin in the cerebrospinal fluid following a subarachnoid hemorrhage: diagnostic implicationsA Petzold, V Worthington, C Pritchard, et al.Neurology|March 29, 2006
Axonal damage markers in cerebrospinal fluid are increased in ALSJ Brettschneider, A Petzold, S D Süssmuth, et al.Pageof 30